Intravenous Dexmedetomidine for Cesarean Section

• Status: Completed
• Trial end date: 2017-10-05
• Target enrollment: 0
• Participant gender: Female

Summary

Nervous, anxiety, fear and other psychological reactions always appears in parturients during cesarean section. This study intends to investigate the effectiveness and safety of dexmedetomidine combined with butorphanol tartrate for postoperative analgesia and breastfeeding after caesarean section.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: The First Affiliated Hospital with Nanjing Medical University
• Treatments: Butorphanol; Dexmedetomidine

Criteria

Inclusion Criteria:

1. Parturients who had successfully breastfed a prior infant and planned to breastfeed after this delivery were screened for eligibility.

2. Parturients undergoing elective caesarean delivery under epidural anaesthesia

3. ASA I and II parturients aged 18-45 years, with singleton gestation.

4. Parturients with verbal and written mandarin

5. Parturients who want to use PCA intravenous analgesia and can use the pump correctly

6. written informed consent.

Exclusion Criteria

1. Multiple gestation.

2. A history of allergy to dexmedetomidine or other study drugs

3. Cardiovascular disease (basic HR<50bpm or SBP<100mmHg)

4. Opioid drugs abuse.

5. BMI more than 35 kg/m2

6. Conditions that preclude spinal anesthesia.

7. Preeclampsia or epilepsy.

8. A history of neuromuscular disease.

9. Epidural anaesthesia was unsuccessful.

10. The parturients, whose surgery ended after 11 a.m.